Inventor

FABRITIUS CHARLES-HENRY

PL8 patents

⚠️ This page may combine multiple inventors who share the name “FABRITIUS CHARLES-HENRY”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.

TOLREMO THERAPEUTICS AG

3 patents

US12595258B2Apr 7, 2026

Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer

TOLREMO THERAPEUTICS AG0 citations47

US12472179B2Nov 18, 2025

Combination of a CBP/p300 bromodomain inhibitor and a KRAS inhibitor for the treatment of cancer

TOLREMO THERAPEUTICS AG0 citations47

US12478624B2Nov 25, 2025

Heterocyclic derivatives, pharmaceutical compositions and their use in the treatment or amelioration of cancer

TOLREMO THERAPEUTICS AG0 citations33

RYVU THERAPEUTICS S A

2 patents

US12344606B2Jul 1, 2025

Next-generation modulators of stimulator of interferon genes (STING)

RYVU THERAPEUTICS S A2 citations59

US12162863B2Dec 10, 2024

Modulators of stimulator of interferon genes (STING)

RYVU THERAPEUTICS S A2 citations47

ZHANG LIXIN

1 patent

US9221838B2Dec 29, 2015

Inhibitors of AKT activity

ZHANG LIXIN4 citations68

FELICITEX THERAPEUTICS INC

1 patent

US10577365B2Mar 3, 2020

Derivatives of quinoline as inhibitors of DYRK1A and/or DYRK1B kinases

FELICITEX THERAPEUTICS INC1 citations49

NODTHERA LTD

1 patent

US11345669B2May 31, 2022

Urea derivatives and methods of use thereof

NODTHERA LTD0 citations40